Logo image of EVOL

EVOLVING SYSTEMS INC (EVOL) Stock Fundamental Analysis

NASDAQ:EVOL - Nasdaq - US30049R2094 - Common Stock

1.08  -0.09 (-7.69%)

After market: 1.09 +0.01 (+0.93%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EVOL. EVOL was compared to 283 industry peers in the Software industry. The financial health of EVOL is average, but there are quite some concerns on its profitability. EVOL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EVOL was profitable.
EVOL Yearly Net Income VS EBIT VS OCF VS FCFEVOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA 3.53%
ROE 6.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVOL Yearly ROA, ROE, ROICEVOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -20 -40 -60 -80 -100

1.3 Margins

Industry RankSector Rank
OM 4.6%
PM (TTM) 2.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVOL Yearly Profit, Operating, Gross MarginsEVOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

EVOL has more shares outstanding than it did 1 year ago.
EVOL has a better debt/assets ratio than last year.
EVOL Yearly Shares OutstandingEVOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2M 4M 6M 8M 10M
EVOL Yearly Total Debt VS Total AssetsEVOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -2.71, we must say that EVOL is in the distress zone and has some risk of bankruptcy.
EVOL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.71
ROIC/WACCN/A
WACCN/A
EVOL Yearly LT Debt VS Equity VS FCFEVOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.65 indicates that EVOL should not have too much problems paying its short term obligations.
EVOL has a Quick Ratio of 1.65. This is a normal value and indicates that EVOL is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
EVOL Yearly Current Assets VS Current LiabilitesEVOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 152.18% over the past year.
The earnings per share for EVOL have been decreasing by -12.39% on average. This is quite bad
The Revenue has been growing slightly by 5.06% in the past year.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)152.18%
EPS 3Y-15.48%
EPS 5Y-12.39%
EPS Q2Q%-46.42%
Revenue 1Y (TTM)5.06%
Revenue growth 3Y-2.93%
Revenue growth 5Y0.59%
Sales Q2Q%3.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVOL Yearly Revenue VS EstimatesEVOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 10M 20M 30M
EVOL Yearly EPS VS EstimatesEVOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 0.1 0.2 0.3 0.4 0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.71 indicates a rather cheap valuation of EVOL.
EVOL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
Industry RankSector Rank
PE 7.71
Fwd PE N/A
EVOL Price Earnings VS Forward Price EarningsEVOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.75
EVOL Per share dataEVOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVOL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

EVOLVING SYSTEMS INC

NASDAQ:EVOL (4/22/2022, 8:00:02 PM)

After market: 1.09 +0.01 (+0.93%)

1.08

-0.09 (-7.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-01 2022-04-01/amc
Earnings (Next)05-11 2022-05-11
Inst Owners2.74%
Inst Owner Change0%
Ins Owners19.24%
Ins Owner Change0%
Market Cap13.32M
Analysts82.86
Price TargetN/A
Short Float %0.02%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.71
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB N/A
EV/EBITDA 3.75
EPS(TTM)0.14
EY12.96%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.22
BVpS0.81
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 6.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.6%
PM (TTM) 2.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -2.71
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.18%
EPS 3Y-15.48%
EPS 5Y-12.39%
EPS Q2Q%-46.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.06%
Revenue growth 3Y-2.93%
Revenue growth 5Y0.59%
Sales Q2Q%3.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A